Bazzichi, Laura
Nacci, Francesca
Sinigaglia, Luigi
Bianchino, Laura
Caporali, Roberto
Funding for this research was provided by:
Roche S.p.A.
Article History
Received: 12 June 2018
Revised: 28 September 2018
Accepted: 8 October 2018
First Online: 12 November 2018
Compliance with ethical standards
: The study was approved by each institutional ethics committee/review board, and all patients provided written informed consent. The study was conducted in accordance with the principles of the Declaration of Helsinki and Good Clinical Practice.
: Laura Bazzichi received fees for consultation from Roche, AbbVie, BMS, Pfizer, and Merck (less than $10,000 per year, overall); Francesca Nacci has nothing to disclose; Luigi Sinigaglia has nothing to disclose; Laura Bianchino is a Roche employee; and Roberto Caporali received fees for consultation and speaker’s activity from AbbVie, UCB, MSD, Italfarmaco, Roche, Pfizer, Lilly, and Novartis (less than $10,000 per year, overall).